Unicorn Portfolio Update 1

#3 of 20 stocks added to the Unicorn Portfolio. $INMD

FU Investments has initiated a buy of InMode. We are starting with a 50% position in our Unicorn Portfolio. InMode is a minimally/non-invasive aesthetics  device manufacturer. They have impeccable financials, with great margins and a flawless balance sheet.   Although growth has slowed after 2021, the current valuation of a Forward P/E of 13.15 represents significant upside potential.  An article with more details about this global provider of innovative medical solutions will follow. We will also be releasing our very exciting article on Beam Therapeutics and the CRISPR race soon.

Portfolio Update

• Buy $250 INMD at $26.14